|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.550 USD | -2.99% |
|
-2.05% | -54.18% |
| 06-30 | Lexeo Therapeutics, Inc. - Special Call | |
| 06-17 | Lexeo Therapeutics Publishes Phase I/Ii Data for Lx2006 in Friedreich Ataxia in Jama Cardiology | CI |
| Market Cap | 357M 313M 289M 266M 502M 34.45B 510M 3.46B 1.36B 16.86B 1.34B 1.31B 58.08B | P/E 2026 * |
-3.88x | P/E 2027 * | -3.41x |
|---|---|---|---|---|---|
| Enterprise Value | 214M 188M 174M 160M 301M 20.66B 306M 2.08B 814M 10.11B 805M 787M 34.83B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 14.3x |
| Free-Float |
99.39% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lexeo Therapeutics, Inc.
| 1 day | -2.99% | ||
| 1 week | -2.05% | ||
| Current month | -2.26% | ||
| 1 month | -7.71% | ||
| 3 months | -30.32% | ||
| 6 months | -37.33% | ||
| Current year | -54.18% |
| 1 week | 4.4 |  | 4.84 |
| 1 month | 4.33 | | 5.38 |
| Current year | 4.03 | | 10.75 |
| 1 year | 3.6 | | 10.99 |
| 3 years | 1.45 | | 22.33 |
| 5 years | 1.45 | | 22.33 |
| 10 years | 1.45 | | 22.33 |
| Manager | Title | Age | Since |
|---|---|---|---|
R. Townsend
CEO | Chief Executive Officer | 46 | 01/01/2020 |
Louis Tamayo
DFI | Director of Finance/CFO | 50 | 15/08/2025 |
| Chief Tech/Sci/R&D Officer | 62 | 20/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
R. Townsend
BRD | Director/Board Member | 46 | 01/01/2020 |
| Chairman | 72 | 01/01/2021 | |
Mette Agger
BRD | Director/Board Member | 61 | 01/11/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/1/26 A | Sell | Chief Financial Officer | -4,641 | 0.0059% | ||
| 7/1/26 A | Sell | Chief Operating Officer | -4,666 | 0.0059% | ||
| 7/1/26 A | Sell | Chief Technology Officer | -22,306 | 0.0284% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.99% | -2.05% | +9.64% | - | 368M | |
| +0.21% | -0.79% | +53.17% | +57.39% | 53.83B | |
| +5.37% | +3.31% | +50.39% | +83.65% | 52.1B | |
| -1.20% | -1.94% | +4.35% | +402.68% | 23.48B | |
| +0.74% | +2.32% | -16.23% | -14.44% | 23.13B | |
| +3.46% | +2.52% | +34.01% | -5.41% | 19.36B | |
| -1.18% | -2.97% | +30.12% | -33.30% | 17.56B | |
| -1.67% | -6.00% | +163.95% | +284.69% | 15.2B | |
| +3.62% | 0.00% | +29.70% | +643.91% | 14.83B | |
| -0.70% | -0.91% | +24.87% | +179.47% | 14.06B | |
| Average | +0.57% | -1.71% | +38.40% | +177.63% | 23.39B | |
| Weighted average by Cap. | +1.47% | -1.50% | +41.41% | +138.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 6.11M 5.36M 4.95M 4.55M 8.59M 589M 8.73M 59.2M 23.21M 288M 22.95M 22.45M 993M |
| Net income | -97.88M -85.79M -79.3M -72.93M -138M -9.44B -140M -948M -372M -4.62B -368M -360M -15.91B | -123M -108M -99.76M -91.75M -173M -11.87B -176M -1.19B -468M -5.81B -462M -452M -20.02B |
| Net Debt | -143M -125M -116M -107M -201M -13.79B -204M -1.39B -543M -6.75B -537M -525M -23.25B | -270M -236M -219M -201M -379M -26.01B -385M -2.61B -1.02B -12.73B -1.01B -991M -43.84B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | $4.550 | -2.99% | 414,956 |
| 17/07/26 | $4.690 | +2.85% | 730,135 |
| 16/07/26 | $4.560 | -3.80% | 780,226 |
| 15/07/26 | $4.740 | +2.60% | 772,115 |
| 14/07/26 | $4.620 | -0.54% | 606,557 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXEO Stock
Select your edition
All financial news and data tailored to specific country editions
